Mr. Zhang Dan
• Foreign academician of Russian Academy of Engineering, co-founder and co-chairman of Hillgene Biology
• Doctor of Medicine, Peking Union Medical College; Master of Public Health, Harvard University; Master of Management, Wharton School, University of Pennsylvania
• Director of China Pharmaceutical Innovation Promotion Association, Vice Chairman of Innovation Research and Development Service Committee
• Responsible expert of the national “13th Five-Year Plan” major New drug development plan
• Head of ICHE19 IFPMA Expert Committee, expert of NMPA ICH Working Group.
• Chief scientist of Xingwan Biology, co-founder of Kunling Medicine, former first chairman of Quintiles Greater China, senior CRO industry entrepreneur and entrepreneur
• Successful approval of domestic and foreign innovative drugs leading dozens of innovative drugs